AstraZeneca Resumes Vaccine Trial in Japan; U.S. Still on Hold

A vaccine trial for a front-runner Covid-19 shot from AstraZeneca Plc and the University of Oxford restarted in Japan after studies were halted globally last month when a U.K. participant became ill.